CN104491687A - 一种治疗抑郁症的中药胶囊及其制备方法 - Google Patents
一种治疗抑郁症的中药胶囊及其制备方法 Download PDFInfo
- Publication number
- CN104491687A CN104491687A CN201410714136.9A CN201410714136A CN104491687A CN 104491687 A CN104491687 A CN 104491687A CN 201410714136 A CN201410714136 A CN 201410714136A CN 104491687 A CN104491687 A CN 104491687A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- traditional chinese
- depression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 34
- 239000003814 drug Substances 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 241000628997 Flos Species 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 241000489492 Arisaema Species 0.000 claims abstract description 9
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 9
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 9
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 210000000941 bile Anatomy 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000011049 filling Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 5
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 5
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000011812 mixed powder Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 240000006365 Vitis vinifera Species 0.000 claims 1
- 230000006870 function Effects 0.000 abstract description 10
- 230000001914 calming effect Effects 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 7
- 210000004185 liver Anatomy 0.000 abstract description 7
- 210000002784 stomach Anatomy 0.000 abstract description 7
- 230000002936 tranquilizing effect Effects 0.000 abstract description 7
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001522232 Pinellia ternata Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 14
- 206010062717 Increased upper airway secretion Diseases 0.000 description 11
- 208000026435 phlegm Diseases 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 4
- 241000219095 Vitis Species 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 206010054089 Depressive symptom Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000994 depressogenic effect Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000036651 mood Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- YXBUQQDFTYOHQI-UHFFFAOYSA-N Pseudohypericin Chemical compound OC1=CC(O)=C2C(=O)C3=C(O)C=C(C)C4=C3C3=C2C1=C(C(O)=CC(O)=C1C2=O)C1=C3C1=C2C(O)=CC(CO)=C14 YXBUQQDFTYOHQI-UHFFFAOYSA-N 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- SSKVDVBQSWQEGJ-UHFFFAOYSA-N pseudohypericin Natural products C12=C(O)C=C(O)C(C(C=3C(O)=CC(O)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 SSKVDVBQSWQEGJ-UHFFFAOYSA-N 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000026872 Addison Disease Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000020925 Bipolar disease Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012373 Depressed level of consciousness Diseases 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000010067 Pituitary ACTH Hypersecretion Diseases 0.000 description 1
- 208000020627 Pituitary-dependent Cushing syndrome Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000006397 emotional response Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229960002464 fluoxetine Drugs 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- BTXNYTINYBABQR-UHFFFAOYSA-N hypericin Chemical compound C12=C(O)C=C(O)C(C(C=3C(O)=CC(C)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 BTXNYTINYBABQR-UHFFFAOYSA-N 0.000 description 1
- 229940005608 hypericin Drugs 0.000 description 1
- PHOKTTKFQUYZPI-UHFFFAOYSA-N hypericin Natural products Cc1cc(O)c2c3C(=O)C(=Cc4c(O)c5c(O)cc(O)c6c7C(=O)C(=Cc8c(C)c1c2c(c78)c(c34)c56)O)O PHOKTTKFQUYZPI-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000003236 psychic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种中药胶囊,具体涉及一种治疗抑郁症的中药胶囊及其制备方法。中药胶囊按照重量份数计,由以下中药原料配制而成:贯叶金丝桃10-15份,郁金10-15份,灵芝2-5份,茯苓5-7份,合欢花5-7份,石菖蒲10-15份,远志8-10份,绿萼梅10-15份,龙齿8-10份,浮小麦8-10份,炙甘草6-8份,白术6-8份,龙眼肉10-15份,当归10-15份,龙骨2-5份,生地2-5份,胆南星2-5份,半夏2-5份。本发明能够调节人体机能、改善心烦意乱,并具有平肝和胃,宁心安神的功效,安全性高、无毒副作用、无依赖性,可以推广使用。
Description
技术领域
本发明涉及一种中药胶囊,具体涉及一种治疗抑郁症的中药胶囊及其制备方法。
背景技术
抑郁症是一种常见的情感和精神障碍性疾病,随着社会生活节奏的加快,抑郁症已成为当今社会的高发疾病。在当前的生活中,充满了大大小小的挫折和失败,很多人都会经历失业、离婚、失去心爱的人,或其他各种痛苦。常常我们最梦寐以求的东西,它再也不存在了,常常我们最爱的人,再也不能回到我们身边。每当这些时刻来临的时候,我们都会体验到悲伤、痛苦、甚至绝望。通常,由这些明确现实事件引起的抑郁和悲伤,是正常的、短暂的,有的甚至有利于个体的成长。但是,有些人的抑郁症状并没有十分明确、合理的外部诱因;另外一些人,虽然在他们的生活中发生了一些负性生活事件,但是,他们的抑郁症状持续得很久,远远超过了一般人对这些事件的情绪反应,而且抑郁症状日趋恶化,严重地影响了工作、生活和学习。如果是这样,那么很可能,他们患了当今世界第一大心理疾病---抑郁症。
抑郁就在我们的生活中,就在我们周围,随时随地都可能会发生。到目前为止,抑郁症确切的病因还不清楚。随着医学模式从过去的生物医学转变到现在的生物、心理、社会医学模式,抑郁症和其他疾病一样,应该从这三个角度去分析病因,即生物因素、心理因素和社会因素。
人生活在社会中,其寿命、健康和疾病无不与之息息相关,人的烦恼、幸福、悲痛、舒畅、焦虑等,这一切维持或破坏人的正常生理功能的情绪都与社会紧密相连。生活条件包括社会、文化和客观环境的变化,婚姻、家庭、个人身体状况和人际关系的变化,经济条件的变化,个人学业成败等。生活中凡能造成强大的精神压力,严重的精神创伤或不愉快的情感体验等条件都可成为心理因素。
有关抑郁症的生物学病因早在30多年前即已被认识,随着研究技术的发展,取得了很大的进展,加深了对抑郁症的病因、病理生理的认识,比较突出的认识是,体内某些物质所致神经质的变化,如:(1)去甲肾上腺学说(NE):当时认为抑郁症是脑内儿茶酚胺,尤其是NE的缺乏或相对缺乏所致。从临床治疗上可以得到某些验证,然而这单一学说仍存在不少问题。(2)五羟色胺学说(5-HT):近些年来对该假说的研究越来越深入,与情感活动有关的受体现血亚型也很多,不同的受体亚型功能又各异,从治疗的角度支持抑郁症与5-HT功能障碍的有关学说。
很多内分泌疾病,如甲状腺功能亢进或低下,Addison病、柯兴氏病等可伴有情感症状,各种激素可引起心境高涨或低落,使人们想到神经内分泌与抑郁症之间可能有关系,也积累了大量研究资料。近年来,由于生物技术的发展,电子计算机扫描(CT)、核磁共振(MRI)、正电子发射扫描(PET)和单光子发射计算机扫描(SPECT)的临床应用,人们也发现抑郁症病人的脑功能或脑结构可能有改变。也有人与遗传因素、个性特点有关。总之,抑郁症的病因复杂,目前世界各国仍在不断研究之中。因此,加强治疗抑郁症的药物研究具有重要的社会和经济意义。
发明内容
根据以上现有技术的不足,本发明提供了一种能够疏肝解郁、宁心安神的疗效更好、更方便的治疗抑郁症的中药胶囊及其制备方法。
本发明所述的一种治疗抑郁症的中药胶囊,按照重量份数计,由以下中药原料配制而成:贯叶金丝桃10-15份,郁金10-15份,灵芝2-5份,茯苓5-7份,合欢花5-7份,石菖蒲10-15份,远志8-10份,绿萼梅10-15份,龙齿8-10份,浮小麦8-10份,炙甘草6-8份,白术6-8份,龙眼肉10-15份,当归10-15份,龙骨2-5份,生地2-5份,胆南星2-5份,半夏2-5份。
一种治疗抑郁症的中药胶囊,按照重量份数计,优选由以下中药原料配制而成:贯叶金丝桃12份,郁金13份,灵芝4份,茯苓6份,合欢花6份,石菖蒲13份,远志9份,绿萼梅13份,龙齿9份,浮小麦9份,炙甘草7份,白术7份,龙眼肉13份,当归12份,龙骨3份,生地4份,胆南星3份,半夏4份。
一种治疗抑郁症的中药胶囊的制备方法,包括以下步骤:
1)按上述重量比称取原料药加水煎煮两次,每次加6倍量水,第一次煎煮2小时,第二次煎煮1小时,合并滤液,过滤后,干燥成细粉;
2)将步骤1)中的细粉加入无水葡萄糖粉混合均匀;
3)将上述混合粉末放入胶囊填充机进行充填,即得到每粒0.5-0.6克的胶囊。
服用方法:每日三次,每次2粒,温水送服,5天为一个疗程。
药理分析:
贯叶金丝桃:主要成分为金丝桃素、伪金丝桃素等具有抗抑郁、抗病毒、治疗创伤等多种作用。三级干热,味微苦,生干生热,通经,通尿,通阻滞,止疼痛,除腐生肌。
郁金:活血止痛,行气解郁,凉血清心,利胆退黄,用于神志不清,血瘀内阻等。
灵芝:安神,保神,入心生血,助心充脉,益肝、肺、脾,防癌抗肿瘤,抗放射,防止肝炎、强心,协调人体新陈代谢,久服轻身不老,延年益寿,含多种氨基酸。
茯苓:味甘淡性平,入药具有利水渗湿、益脾和胃、宁心安神之功用。
合欢花:味甘,性平,有解除抑郁,安五脏,明目的作用,可治疗精神忧郁引起的失眠及双目昏暗,安神解郁,活血消肿,用于情志所伤的愤怒忧郁,虚烦不安。
石菖蒲:味辛、苦,性温。归心、胃经。能够化湿开胃,开窍豁痰,醒神益智。用于脘痞不饥,噤口下痢,神昏癫痫,健忘耳聋。改善记忆能力、扩张血管、降压等作用。
远志:性温,味苦、辛,具有安神益智、祛痰、消肿的功能,用于心肾不交引起的老年痴呆多梦、健忘惊悸,神志恍惚,咳痰不爽,疮疡肿毒,乳房肿痛。
绿萼梅:味苦、微甘,性平。能够平肝和胃。用于胸胁胀痛,胃痛,消化不良,神经衰弱。
龙齿:味甘,涩,性凉。能够宁心安神。用于神经衰弱,头晕目眩,心悸,失眠。
浮小麦:味甘,性凉。能够止虚汗,养心安神。用于体虚多汗,狂躁症。
炙甘草:味甘,性平。归心、肺、脾、胃经。补脾和胃,益气复脉。具有益气滋阴,通阳复脉治疗功效;和中缓急,润肺,解毒,调和诸药;常用于脾胃虚弱,倦怠乏力,心动悸,脉结代,可解附子毒。
白术:本品甘苦性温,主归脾胃经,以健脾、燥湿为主要作用,被前人誉之为“脾脏补气健脾第一要药”。脾主运化因脾气不足,运化失健,往往水湿内生,引起食少、便溏或泄泻、痰饮、水肿、带下诸证。
龙眼肉:味甘,性温。归心、脾经。能够补益心脾,养血安神。用于气血不足,心悸怔忡,健忘失眠,血虚萎黄。
当归:味甘、辛,性温。归肝、心、脾经。补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡。酒当归活血通经。用于经闭痛经,风湿痹痛,跌扑损伤。
龙骨:味甘涩性微寒,平肝宁心,益心肝之阴,重镇安神镇惊安神,敛汗固精,止血涩肠,生肌敛疮;治惊痫癫狂,怔忡健忘,失眠多梦,自汗盗汗,遗精淋浊,吐衄便血,崩漏带下,泻痢脱肛,溃疡久不收口。
生地:清热生津,凉后,止血,养阴,生津;用于热病烦渴、发斑发疹、阴虚内热、吐血、衄血、糖尿病、传染性肝炎。
胆南星:味苦、微辛,性凉。归肺、肝、脾经。能够清热化痰,息风定惊。用于痰热咳嗽,咯痰黄稠,中风痰迷,癫狂惊痫。
半夏:味辛,性温。有毒。归脾、胃、肺经。气微,味微涩;功能燥湿化痰,降逆止呕,消痞散结。用于痰多咳喘,痰饮眩悸,风痰眩晕,痰厥头痛,呕吐反胃,胸脘痞闷,梅核气。
本发明能够调节人体机能、改善心烦意乱,并具有平肝和胃,宁心安神的功效,安全性高、无毒副作用、无依赖性,可以推广使用。
收集120例抑郁症患者,随机分为治疗组1、治疗组2、治疗组3、对照组(服用氟西汀),每组60例;男60例,女60例;年龄18-45岁,平均30岁;病程最长10年,最短2周,平均约2年。各组患者年龄症状构成无显著差异;治疗组患者每日三次本发明胶囊,每次2粒,温水送服,5天为一个疗程。
疗效评定:
治愈:临床症状消失,不影响工作和学习,随诊2个月无复发;
显效:症状及体征基本消失,仅在少数情况下有轻度症状,不影响工作和生活;
好转:症状减轻,体征改善,但有复发,对人生活工作有影响;
无效:症状体征无明显改善或加重。
3个疗程后,统计结果如下:
治愈 | 显效 | 好转 | 无效 | 有效率 | |
对照组 | 0 | 2 | 4 | 54 | 10% |
治疗组 | 26 | 20 | 12 | 2 | 96.67% |
结果:120例患者中
1、治疗组中显效和治愈了46例,占76.67%;
而对照组显效和治愈了2例,占3.3%。
2、治疗组中好转了12例,占20%;
而对照组好转了4例,占6.67%;
3、总体,药物的有效率中,治疗组占到96.67%,远远超于对照组的10%,所以,本发明药剂对治疗失眠有很好的疗效。
以下列举几个典型病例:
病例一:董某,男,33岁,患者持续性头痛,多年来没有缓解,并且心情时常低落,不愿意工作,也不愿意与其他人沟通、交往,有消极观念,并曾经详细计划服药或者跳楼自杀。后服本发明胶囊药物,一个疗程后,症状缓解,3个疗程后,症状完全消失,现已恢复正常工作生活。
病例二:罗某某,女,41岁,十年前由于与丈夫的姐姐发生争执撕扭,虽然没有对彼此造成明显伤害,但心里一直耿耿于怀,这十余年一直心情低落,紧张害怕,头部长期有紧绷感,来院诊断为抑郁症。后服用本发明实施例配方,每日2次,每次30g,一个月后症状减轻,继续服用3个月症状明显改善,再服用2个月症状完全消失,精力恢复,从事正常工作。随访4个月未见复发。
病例三:孙某,女,16岁,学生。患者处在青春期中,学习压力大,加上家庭为了防止其早恋,对其心理施加压力过大,导致患者天天心情低沉,精神恍惚,心神不宁,莫名哭泣,后确诊为抑郁症。服本发明胶囊药物,2个疗程后彻底治愈,现已恢复正常学习生活,顺利考上大学。
具体实施方式
以下结合实施例对本发明做进一步说明,但本发明并不局限于具体实施例。
实施例1:
一种治疗抑郁症的中药胶囊,按照重量份数计,由以下中药原料配制而成:贯叶金丝桃10份,郁金15份,灵芝2份,茯苓7份,合欢花5份,石菖蒲15份,远志8份,绿萼梅15份,龙齿8份,浮小麦10份,炙甘草6份,白术8份,龙眼肉10份,当归15份,龙骨2份,生地5份,胆南星2份,半夏5份。
实施例2:
一种治疗抑郁症的中药胶囊,按照重量份数计,由以下中药原料配制而成:贯叶金丝桃15份,郁金10份,灵芝5份,茯苓5份,合欢花7份,石菖蒲10份,远志10份,绿萼梅10份,龙齿10份,浮小麦8份,炙甘草8份,白术6份,龙眼肉15份,当归10份,龙骨5份,生地2份,胆南星5份,半夏2份。
实施例3:
一种治疗抑郁症的中药胶囊,按照重量份数计,由以下中药原料配制而成:贯叶金丝桃12份,郁金13份,灵芝4份,茯苓6份,合欢花6份,石菖蒲13份,远志9份,绿萼梅13份,龙齿9份,浮小麦9份,炙甘草7份,白术7份,龙眼肉13份,当归12份,龙骨3份,生地4份,胆南星3份,半夏4份。
实施例4:
一种治疗抑郁症的中药胶囊的制备方法,包括以下步骤:
1)按上述实施例1中称取原料药加水煎煮两次,每次加6倍量水,第一次煎煮2小时,第二次煎煮1小时,合并滤液,过滤后,干燥成细粉;
2)将步骤1)中的细粉加入无水葡萄糖粉混合均匀;
3)将上述混合粉末放入胶囊填充机进行充填,即得到每粒0.5-0.6克的胶囊。
服用方法:每日三次,每次2粒,温水送服,5天为一个疗程。
实施例5:
一种治疗抑郁症的中药胶囊的制备方法,包括以下步骤:
1)按上述实施例2中称取原料药加水煎煮两次,每次加6倍量水,第一次煎煮2小时,第二次煎煮1小时,合并滤液,过滤后,干燥成细粉;
2)将步骤1)中的细粉加入无水葡萄糖粉混合均匀;
3)将上述混合粉末放入胶囊填充机进行充填,即得到每粒0.5-0.6克的胶囊。
服用方法:每日三次,每次2粒,温水送服,5天为一个疗程。
实施例6:
一种治疗抑郁症的中药胶囊的制备方法,包括以下步骤:
1)按上述实施例3中称取原料药加水煎煮两次,每次加6倍量水,第一次煎煮2小时,第二次煎煮1小时,合并滤液,过滤后,干燥成细粉;
2)将步骤1)中的细粉加入无水葡萄糖粉混合均匀;
3)将上述混合粉末放入胶囊填充机进行充填,即得到每粒0.5-0.6克的胶囊。
服用方法:每日三次,每次2粒,温水送服,5天为一个疗程。
以上已将本发明做一详细说明,以上所述,仅为本发明之较佳实施例而已,当不能限定本发明实施范围,即凡依本申请范围所作均等变化与修饰,皆应仍属本发明涵盖范围内。
Claims (3)
1.一种治疗抑郁症的中药胶囊,其特征在于按照重量份数计,由以下中药原料配制而成:贯叶金丝桃10-15份,郁金10-15份,灵芝2-5份,茯苓5-7份,合欢花5-7份,石菖蒲10-15份,远志8-10份,绿萼梅10-15份,龙齿8-10份,浮小麦8-10份,炙甘草6-8份,白术6-8份,龙眼肉10-15份,当归10-15份,龙骨2-5份,生地2-5份,胆南星2-5份,半夏2-5份。
2.根据权利要求1所述的一种治疗抑郁症的中药胶囊,其特征在于按照重量份数计,由以下中药原料配制而成:贯叶金丝桃12份,郁金13份,灵芝4份,茯苓6份,合欢花6份,石菖蒲13份,远志9份,绿萼梅13份,龙齿9份,浮小麦9份,炙甘草7份,白术7份,龙眼肉13份,当归12份,龙骨3份,生地4份,胆南星3份,半夏4份。
3.一种权利要求1所述的治疗抑郁症的中药胶囊的制备方法,其特征在于包括以下步骤:
1)按上述重量比称取原料药加水煎煮两次,每次加6倍量水,第一次煎煮2小时,第二次煎煮1小时,合并滤液,过滤后,干燥成细粉;
2)将步骤1)中的细粉加入无水葡萄糖粉混合均匀;
3)将上述混合粉末放入胶囊填充机进行充填,即得到每粒0.5-0.6克的胶囊。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410714136.9A CN104491687A (zh) | 2014-11-28 | 2014-11-28 | 一种治疗抑郁症的中药胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410714136.9A CN104491687A (zh) | 2014-11-28 | 2014-11-28 | 一种治疗抑郁症的中药胶囊及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104491687A true CN104491687A (zh) | 2015-04-08 |
Family
ID=52933201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410714136.9A Pending CN104491687A (zh) | 2014-11-28 | 2014-11-28 | 一种治疗抑郁症的中药胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104491687A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112843209A (zh) * | 2021-04-14 | 2021-05-28 | 上海中医药大学附属岳阳中西医结合医院 | 一种治疗慢性头晕的中药组合物及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101773641A (zh) * | 2009-01-12 | 2010-07-14 | 北京亚东生物制药有限公司 | 一种舒肝解郁的中药组合物制剂及质量控制方法 |
CN104147518A (zh) * | 2014-08-13 | 2014-11-19 | 高丽丽 | 一种治疗抑郁症的中药胶囊及其制备方法 |
-
2014
- 2014-11-28 CN CN201410714136.9A patent/CN104491687A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101773641A (zh) * | 2009-01-12 | 2010-07-14 | 北京亚东生物制药有限公司 | 一种舒肝解郁的中药组合物制剂及质量控制方法 |
CN104147518A (zh) * | 2014-08-13 | 2014-11-19 | 高丽丽 | 一种治疗抑郁症的中药胶囊及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112843209A (zh) * | 2021-04-14 | 2021-05-28 | 上海中医药大学附属岳阳中西医结合医院 | 一种治疗慢性头晕的中药组合物及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102283999B (zh) | 一种治疗失眠的中药制剂 | |
CN104873745B (zh) | 一种治疗失眠的中药及制备方法 | |
CN102178853B (zh) | 一种治疗小儿癫痫的中药制剂及其制备方法 | |
CN103520505B (zh) | 一种治疗神经衰弱的中药制剂及制备方法 | |
CN105327287A (zh) | 一种治疗精神病的药物组合物及其制备工艺 | |
CN104147518A (zh) | 一种治疗抑郁症的中药胶囊及其制备方法 | |
CN104306678A (zh) | 一种治疗产后抑郁的中药制剂及制备方法 | |
CN1142785C (zh) | 抗疲劳胶囊 | |
CN108310324A (zh) | 一种防治失眠症的中药组合物及其制备方法 | |
CN104491687A (zh) | 一种治疗抑郁症的中药胶囊及其制备方法 | |
CN106361976A (zh) | 一种安神助眠养颜复方制剂及其制备方法 | |
CN103933150B (zh) | 一种具有改变睡眠质量功效的保健口服液 | |
CN105232999A (zh) | 一种补气活血固精的中药组合物 | |
CN101474267B (zh) | 一种治疗精神衰弱失眠心烦的药物 | |
CN102949656A (zh) | 一种用于预防治抑郁症的保健品胶囊及其制备方法 | |
CN104547642A (zh) | 一种治疗女性纤维肌痛综合征的中药组合物 | |
CN104606469A (zh) | 一种治疗失眠的中药组合物 | |
CN104688855B (zh) | 一种治疗慢性疲劳综合症的黄连阿胶组合物及其应用 | |
CN105770714A (zh) | 一种治疗抑郁症的中药胶囊及其制备方法 | |
CN104223062B (zh) | 一种降压降糖的地骨皮保健口服液及其制备方法 | |
CN103202964A (zh) | 益脑安神药酒 | |
CN103479868B (zh) | 一种治疗心虚胆怯型心律失常的中药及制备方法 | |
CN107737259A (zh) | 一种提高男性性功能的中药组方 | |
CN101972355A (zh) | 一种综合补肾的中药 | |
CN106728258A (zh) | 一种安神助眠的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150408 |